1. Home
  2. MIRM vs NVEC Comparison

MIRM vs NVEC Comparison

Compare MIRM & NVEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mirum Pharmaceuticals Inc.

MIRM

Mirum Pharmaceuticals Inc.

HOLD

Current Price

$65.05

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Logo NVE Corporation

NVEC

NVE Corporation

HOLD

Current Price

$70.55

Market Cap

328.9M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
MIRM
NVEC
Founded
2018
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
328.9M
IPO Year
2019
1996

Fundamental Metrics

Financial Performance
Metric
MIRM
NVEC
Price
$65.05
$70.55
Analyst Decision
Strong Buy
Analyst Count
11
0
Target Price
$87.55
N/A
AVG Volume (30 Days)
560.0K
50.7K
Earning Date
11-04-2025
01-21-2026
Dividend Yield
N/A
5.66%
EPS Growth
N/A
N/A
EPS
N/A
2.85
Revenue
$471,794,000.00
$24,784,396.00
Revenue This Year
$53.78
N/A
Revenue Next Year
$19.91
N/A
P/E Ratio
N/A
$24.79
Revenue Growth
53.66
N/A
52 Week Low
$36.88
$51.50
52 Week High
$78.55
$88.50

Technical Indicators

Market Signals
Indicator
MIRM
NVEC
Relative Strength Index (RSI) 36.47 61.79
Support Level $63.66 $62.71
Resistance Level $66.77 $66.26
Average True Range (ATR) 2.99 2.16
MACD -0.66 1.25
Stochastic Oscillator 13.68 77.96

Price Performance

Historical Comparison
MIRM
NVEC

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

About NVEC NVE Corporation

NVE Corp develops and sells devices that use spintronics, a nanotechnology that relies on electron spin. It manufactures high-performance spintronic products including sensors and couplers that are used to acquire and transmit data. The company's products include Digital sensors, Medical sensors, Rotation Sensors, GT Sensors, Angle Sensors, Analog sensors, MSOP Isolators, Passive-In Transceivers, and others. The company manufactures high-performance spintronic products including sensors and couplers. The company's designs are based on giant magnetoresistance GMR and tunneling magnetoresistance TMR combined with integrated circuitry.

Share on Social Networks: